160 related articles for article (PubMed ID: 32417663)
1. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2020 Aug; 43():102178. PubMed ID: 32417663
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Ashtari F; Baghbanian SM; Razazian N; Moghadasi AN; Bayati A; Azimi AR; Beladimoghadam N; Harirchian MH; Poursadeghfard M; Navardi S; Shirkoohi R; Heidari H; Ghaffari M; Eskandarieh S
BMC Neurol; 2022 Mar; 22(1):76. PubMed ID: 35248009
[TBL] [Abstract][Full Text] [Related]
3. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran.
Faraji F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Dec; 68():104231. PubMed ID: 36270251
[TBL] [Abstract][Full Text] [Related]
5. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
6. Pediatric multiple sclerosis and its familial recurrence: A population based study (1999-2017).
Eskandarieh S; Sahraiain MA; Molazadeh N; Moghadasi AN
Mult Scler Relat Disord; 2019 Nov; 36():101377. PubMed ID: 31473489
[TBL] [Abstract][Full Text] [Related]
7. The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.
Ezabadi SG; Ayoubi S; Sahraian MA; Omrani MA; Eskandarieh S
Neurol Sci; 2023 Dec; 44(12):4517-4518. PubMed ID: 37642789
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
[TBL] [Abstract][Full Text] [Related]
9. Familial vs sporadic multiple sclerosis in the Israeli population: Differences in ethnicity distribution and disease progression, with anticipation in successive generations.
Kugelman N; Staun-Ram E; Volkovitz A; Barnett-Griness O; Glass-Marmor L; Miller A
Mult Scler Relat Disord; 2024 Jul; 87():105604. PubMed ID: 38718750
[TBL] [Abstract][Full Text] [Related]
10. Disease onset in familial and sporadic multiple sclerosis in Argentina.
Rojas JI; Patrucco L; MIguez J; Sinay V; Cassara FP; Cáceres F; Liguori NF; Saladino ML; Deri N; Jaacks G; Marcilla MP; Arrigoni MI; Correale J; Fiol M; Ysrraelit MC; Carrá A; Curbelo MC; Martinez A; Steinberg J; Bestoso S; Hryb JP; Di Pace JL; Perassolo MB; Carnero Contentti E; Caride A; Lopez PA; Martinez C; Reich E; Cristiano E
Mult Scler Relat Disord; 2016 Mar; 6():54-56. PubMed ID: 27063623
[TBL] [Abstract][Full Text] [Related]
11. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
12. Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease.
Katsavos S; Artemiadis A; Davaki P; Stamboulis E; Kilindireas K; Anagnostouli M
Clin Neurol Neurosurg; 2018 Oct; 173():144-149. PubMed ID: 30125837
[TBL] [Abstract][Full Text] [Related]
13. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
14. [Familial multiple sclerosis in Canary Islands].
Amela-Peris R; Aladro Y; Conde-Sendín MA; Alemany-Rodríguez MJ; Muñoz-Fernández C; Reyes-Yáñez MP; Déniz-Naranjo MC; Sánchez-García F
Rev Neurol; 2004 Nov 16-30; 39(10):911-4. PubMed ID: 15573304
[TBL] [Abstract][Full Text] [Related]
15. Exclusive breastfeeding may be a protective factor in individuals with familial multiple sclerosis. A population registry-based case-control study.
Jovanovic A; Pekmezovic T; Mesaros S; Novakovic I; Peterlin B; Veselinovic N; Tamas O; Ivanovic J; Maric G; Andabaka M; Momcilovic N; Drulovic J
Mult Scler Relat Disord; 2024 Feb; 82():105392. PubMed ID: 38159366
[TBL] [Abstract][Full Text] [Related]
16. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
18. The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.
Ehtesham N; Rafie MZ; Mosallaei M
BMC Neurol; 2021 Jun; 21(1):246. PubMed ID: 34182943
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.
Eskandarieh S; Heydarpour P; Elhami SR; Sahraian MA
Iran J Public Health; 2017 May; 46(5):699-704. PubMed ID: 28560202
[TBL] [Abstract][Full Text] [Related]
20. MRI but not demographic or clinical characteristics differ between familial and sporadic MS cases.
Moghadam NB; Ghaffari M; Rashed SS; Valaie N; Hesami O; Niloofar P; Ghazanfari Y
Mult Scler Relat Disord; 2021 Nov; 56():103235. PubMed ID: 34678703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
